Exact Mass: 493.17365820000003
Exact Mass Matches: 493.17365820000003
Found 46 metabolites which its exact mass value is equals to given mass value 493.17365820000003,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Dasabuvir
C26H27N3O5S (493.1671332000001)
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AP - Antivirals for treatment of hcv infections C254 - Anti-Infective Agent > C281 - Antiviral Agent
Asp Ser Ser Trp
C21H27N5O9 (493.1808692000001)
Asp Ser Trp Ser
C21H27N5O9 (493.1808692000001)
Asp Trp Ser Ser
C21H27N5O9 (493.1808692000001)
Ser Asp Ser Trp
C21H27N5O9 (493.1808692000001)
Ser Asp Trp Ser
C21H27N5O9 (493.1808692000001)
Ser Ser Asp Trp
C21H27N5O9 (493.1808692000001)
Ser Ser Trp Asp
C21H27N5O9 (493.1808692000001)
Ser Trp Asp Ser
C21H27N5O9 (493.1808692000001)
Ser Trp Ser Asp
C21H27N5O9 (493.1808692000001)
Trp Asp Ser Ser
C21H27N5O9 (493.1808692000001)
Trp Ser Asp Ser
C21H27N5O9 (493.1808692000001)
Trp Ser Ser Asp
C21H27N5O9 (493.1808692000001)
(2R,3R)-2,3-dihydroxybutanedioic acid,5-fluoro-1-(2-fluorophenyl)-3-[[(3S)-piperidin-3-yl]methoxy]indazole
C23H25F2N3O7 (493.16604839999997)
Apatinib
C25H27N5O4S (493.1783662000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents
4-[4,6-bis(4-phenylphenyl)-1H-1,3,5-triazin-2-ylidene]-3-hydroxycyclohexa-2,5-dien-1-one
N-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyl)-3-fluorenylcarboxamide
NGB 2904 is a potent, selective, orally active and brain-penetrated antagonist of dopamine D3 receptor, with a Ki of 1.4 nM. NGB 2904 shows selectivity for D3 over D2, 5-HT2, α1, D4, D1 and D5 receptors (Kis=217, 223, 642, >5000, >10000 and >10000 nM, respectively). NGB 2904 antagonizes Quinpirole-stimulated mitogenesis[1][2].
Dasabuvir
C26H27N3O5S (493.1671332000001)
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AP - Antivirals for treatment of hcv infections C254 - Anti-Infective Agent > C281 - Antiviral Agent
(E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)octan-1-imine
4-[3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4,6-dimethyl-9-oxoimidazo[1,2-a]purin-7-yl]-2-(methoxycarbonylamino)butanoate
C20H25N6O9- (493.16829399999995)
[4-[2-(3-Chlorophenyl)-5-phenyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]-phenylmethanone
2-[5-[[2-(3-methoxypropylamino)-2-oxoethyl]thio]-3-oxo-2H-imidazo[1,2-c]quinazolin-2-yl]-N-(phenylmethyl)acetamide
C25H27N5O4S (493.1783662000001)
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C24H26F3N3O5 (493.1824462000001)
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C24H26F3N3O5 (493.1824462000001)
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C24H26F3N3O5 (493.1824462000001)
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C24H26F3N3O5 (493.1824462000001)
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C24H26F3N3O5 (493.1824462000001)
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C24H26F3N3O5 (493.1824462000001)
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C24H26F3N3O5 (493.1824462000001)
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C24H26F3N3O5 (493.1824462000001)
(11r,15s,16s)-14,15-dimethoxy-20-methyl-19-oxo-5,7,21-trioxa-20-azahexacyclo[11.4.3.1¹¹,¹⁴.0¹,¹³.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9-trien-16-yl benzoate
C27H27NO8 (493.17365820000003)
(1r,11s,13s,14r,15s,16s)-14,15-dimethoxy-20-methyl-19-oxo-5,7,21-trioxa-20-azahexacyclo[11.4.3.1¹¹,¹⁴.0¹,¹³.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9-trien-16-yl benzoate
C27H27NO8 (493.17365820000003)
2,3-dihydroxy-6-(3-hydroxy-4-methoxyphenyl)-10,12-dimethoxy-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboximidic acid
C27H27NO8 (493.17365820000003)
(2s,3r,4r,5s,6r)-2,3-dihydroxy-6-(3-hydroxy-4-methoxyphenyl)-10,12-dimethoxy-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboximidic acid
C27H27NO8 (493.17365820000003)
[5-(4-acetyl-2-hydroxyimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]({[2-amino-1,4-dihydroxy-3-methyl-4-(pyridin-2-yl)butylidene]amino})acetic acid
C21H27N5O9 (493.1808692000001)